• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CDC’s ’virtual Human’ Relays Prostate Cancer Info Through Candid Conversations

Share:

October 23, 2020

Last month, the CDC launched a prostate cancer information program with a uniquely digital face: a “virtual human” named Nathan who speaks with men about screening and treatment.

“Talk to Someone About Prostate Cancer” takes the form of an in-browser interactive video developed by health simulation company Kognito, where Nathan introduces himself and prompts the viewer by asking how confident they are talking to their provider about prostate cancer screening. Users indicate their response by clicking one of several text responses, prompting a relevant reply, and kicking off a series of question and answer conversation trees.

Accompanying the interactive tool on the CDC’s site is a resource center with more information about the disease, relevant health tips, statistics, screening risks, and other basic guidance and recommendations. The public health agency notes that the patient-facing tools are also designed for use by providers during a clinical encounter to support shared decision-making skills.

WHY IT MATTERS

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Prostate cancer is among the most common cancers in American men. Thirteen in 100 men will develop prostate cancer during their lifetime, and two or three will die due to it, according to the CDC. Symptoms of the condition greatly vary or do not develop at all, underscoring the need for middle-aged men to speak with their doctor about whether or not they should undergo screening.

But despite the cancer’s prevalence, the CDC noted in a blog post unveiling Nathan that “the decision to be screened and treated for prostate cancer can be overwhelming and complicated.” Some of this is driven by discomfort and long-identified stigma regarding the digital rectal examination, which some doctors use to identify abnormal growth (but which stopped being recommended by the U.S. Preventive Services Task Force in 2018, in favor of a prostate specific antigen test).

Virtual health engagement tools that employ digital avatars can help some patients open up about difficult-to-discuss topics, providing a new way for individuals to become more engaged in their care.

THE LARGER TREND

CDC’s virtual conversation effort comes after this summer’s “Access Initiative for Quitting Tobacco,” a pilot launched by the World Health Organization. It combines free nicotine replacement therapies and conversations with a similar digital human named Florence. That free tool used a microphone and artificial intelligence to interpret spoken questions and prompts from the user, and responded accordingly.

Source: Mobi Health News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • 60% of pharma companies using or trying blockchain – survey60% of pharma companies using or trying blockchain – survey
  • 3 Ways to Leverage RPA for Greater Value: Lessons from Healthcare3 Ways to Leverage RPA for Greater Value: Lessons from Healthcare
  • Imprivata Launches First-to-Market Mobile Facial Recognition SolutionImprivata Launches First-to-Market Mobile Facial Recognition Solution
  • Some NBA Players Skeptical of Wearable Devices to be Used Inside Disney World BubbleSome NBA Players Skeptical of Wearable Devices to be Used Inside Disney World Bubble
  • Harrison Street Acquires Osborn Triangle, a State-of-the-Art Office and Laboratory Complex Located in Cambridge, Mass.Harrison Street Acquires Osborn Triangle, a State-of-the-Art Office and Laboratory Complex Located in Cambridge, Mass.
  • Petauri™ Acquires the Kinetix Group.Petauri™ Acquires the Kinetix Group.
  • Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USAKamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USA
  • Resverlogix Announces New Research Highlighting Apabetalone’s Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19Resverlogix Announces New Research Highlighting Apabetalone’s Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications